The patient's attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of vaginal reconstruction.
It was reported that after implant, the patient experienced urinary tract infection, vulval lichen sclerosis, sepsis, difficulties with bowel motions, diverticulitis, urinary incontinence, urinary retention, peritonitis, hypotension, pain, infection, impairment of household chores/entertainment/physical activities, emotional changes, blood in urine, leukocytes, gram positive cocci resembling staphylococcus epidermis, klebsiella oxytoca, pseudomonas auruginosa, dysuria, nausea, vomiting, pyuria (burning urination), urinary frequency, gastroparesis, sweats, confusion, delirium, rapid decline in strength, lobar pneumonia, septic shock, urosepsis with thick purulent urine, right sided pneumonia, hypotension, hyperkalemia, hyponatremia, abdominal pain, ileus, edema, bilateral nephrosis, chronic liver disease, free intraperitoneal fluid, acute kidney injury, and death.
Post-operative patient treatment included hospitalization, metaraminol infusion, dobutamine, noradrenaline infusions, and medication.
Information received indicates the patient is now deceased, due to multi-organ failure from urinary system and respiratory sepsis, chronic myeloproliferative disorder and diabetes.
|